Literature DB >> 25174767

Kidney involvement in systemic sclerosis.

Virginia D Steen1.   

Abstract

Kidney involvement in systemic sclerosis (SSc) is primarily manifested by scleroderma renal crisis (SRC). Formerly, it was the most severe complication in scleroderma and was the most frequent cause of death in these patients. More than 30years ago, with the development of angiotensin converting enzyme (ACE) inhibitors, SRC became a very treatable complication of scleroderma. Although there are still many patients who do not survive and have poor outcomes, early diagnosis of renal crisis and prompt therapeutic intervention can achieve excellent outcomes. Renal abnormalities independent of renal crisis have been noted, but can usually be attributed to other problems. Further understanding of the pathogenesis of renal disease in scleroderma may lead to additional improvement in the therapy of renal crisis and perhaps the disease in general. This chapter reviews the pathogenesis, clinical setting, and therapy of this serious complication of SSc.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2014        PMID: 25174767     DOI: 10.1016/j.lpm.2014.02.031

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

Review 1.  Kidney involvement in systemic sclerosis: From pathogenesis to treatment.

Authors:  Cosimo Bruni; Giovanna Cuomo; Francesca W Rossi; Emanuela Praino; Silvia Bellando-Randone
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 2.  Corticosteroids in Myositis and Scleroderma.

Authors:  Anna Postolova; Jennifer K Chen; Lorinda Chung
Journal:  Rheum Dis Clin North Am       Date:  2015-10-26       Impact factor: 2.670

3.  Renal pathology and clinical associations in systemic sclerosis: a historical cohort study.

Authors:  Pantipa Tonsawan; Komkid Talabthong; Anucha Puapairoj; Chingching Foocharoen
Journal:  Int J Gen Med       Date:  2019-09-02

4.  Systemic sclerosis medications and risk of scleroderma renal crisis.

Authors:  S M Gordon; J B Hughes; R Nee; R S Stitt; W T Bailey; D J Little; J D Edison; S W Olson
Journal:  BMC Nephrol       Date:  2019-07-25       Impact factor: 2.388

5.  Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease.

Authors:  Sihyung Park; Yoo Jin Lee; Yang Wook Kim; Junghae Ko; Jin Han Park; Il Hwan Kim; Hee-Jin Kim; Doyeun Oh; Bong Soo Park
Journal:  Am J Case Rep       Date:  2020-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.